Answer
Gazyvaro (obinutuzumab) must not be mixed with other medicinal products except those mentioned in section 6.6 of its Summary of Product Characteristics.
Sources for this answer
- Gazyvaro 1,000 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §6.2 Incompatibilities · Version 22Document updated
Sources checked